Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-FR | Version v8-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2023-12-14 | 2023-09-12 |
| Drug Identification Number | 02334992 | 02334992 |
| Brand name | ENDOMETRIN | ENDOMETRIN |
| Common or Proper name | PROGESTIN | PROGESTIN |
| Company Name | FERRING INC | FERRING INC |
| Ingredients | PROGESTERONE | PROGESTERONE |
| Strength(s) | 100MG | 100MG |
| Dosage form(s) | VAGINAL TABLET, EFFERVESCENT | VAGINAL TABLET, EFFERVESCENT |
| Route of administration | VAGINAL VAGINAL | VAGINAL VAGINAL |
| Packaging size | 100 mg effervescent vaginal tablets packed individually in a sealed foil pouch with vaginal applicators. | 100 mg effervescent vaginal tablets packed individually in a sealed foil pouch with vaginal applicators. |
| ATC code | G03DA | G03DA |
| ATC description | PROGESTOGENS | PROGESTOGENS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2023-05-31 | 2023-05-31 |
| Estimated end date | 2024-06-02 | 2024-01-02 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Type II Recall (Retail Level) | Type II Recall (Retail Level) |
| Health Canada comments |